|
|
Volumn 51, Issue 3, 1998, Pages 211-213
|
|
A decade of antidepressant development: The SSRIs and beyond
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
BEFLOXATONE;
CHLORPROMAZINE;
LAMOTRIGINE;
LITHIUM;
MIRTAZAPINE;
MOCLOBEMIDE;
MONOAMINE OXIDASE INHIBITOR;
NEFAZODONE;
REBOXETINE;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
VENLAFAXINE;
DEPRESSION;
EDITORIAL;
HUMAN;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
ANTIDEPRESSIVE AGENTS;
DEPRESSIVE DISORDER;
DRUG INDUSTRY;
HISTORY, 20TH CENTURY;
HUMANS;
MONOAMINE OXIDASE INHIBITORS;
NEUROSCIENCES;
PSYCHOPHARMACOLOGY;
SEROTONIN UPTAKE INHIBITORS;
TECHNOLOGY, PHARMACEUTICAL;
|
|
EID: 0032427569
PISSN: 01650327
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-0327(98)00220-1 Document Type: Editorial |
|
Times cited : (14)
|
|
References (1)
|
